Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2008; 52:1231-1238, doi:10.1016/j.jacc.2008.07.010
© 2008 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow View Related Cardiosource Journal Scan
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosso, R.
Right arrow Articles by Viskin, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Rosso, R.
Right arrow Articles by Viskin, S.
Related Collections
Right arrowRelated Article

J-Point Elevation in Survivors of Primary Ventricular Fibrillation and Matched Control Subjects

Incidence and Clinical Significance

Raphael Rosso, MD*, Evgeni Kogan, MD*, Bernard Belhassen, MD*, Uri Rozovski, MD*, Melvin M. Scheinman, MD§, David Zeltser, MD*, Amir Halkin, MD*, Arie Steinvil, MD*, Karin Heller, MD*, Michael Glikson, MD{dagger}, Amos Katz, MD{ddagger} and Sami Viskin, MD*,*

* Tel Aviv Medical Center, Tel Aviv University, Tel Aviv, Israel
{dagger} Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
{ddagger} Soroka Medical Center and Ben Gurion University, Beer-Sheva, Israel
§ University of California San Francisco, San Francisco, California


Figure 1
View larger version (134K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 1 Electrocardiogram of a 45-Year-Old Man in the Ventricular Fibrillation Group

This patient was eventually diagnosed as Brugada syndrome. Note that leads V1 to V3 do not show any ST-segment elevation. In contrast, the J-point elevation in leads II, III, and aVF is obvious. Note also the ventricular extrasystoles with short coupling interval. The very short coupling interval is best appreciated in lead V2.

 

Figure 2
View larger version (35K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 2 J-Point Elevation and R-Wave Slurring

A and B show the electrocardiograms (leads I to aVF) of 2 male subjects with idiopathic ventricular fibrillation, whereas C shows the electrocardiogram of a healthy male athlete. The lower panel shows enlargements of the respective electrocardiograms. A1 demonstrates J-point elevation (arrows). B1 demonstrates slurring of the QRS (arrowhead). C1 demonstrates J-point elevation (arrows).

 

Figure 3
View larger version (23K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 3 Influence of Gender on the Incidence of J-Point Elevation in the Different Patient Groups

*p < 0.05; **p < 0.005 by Fisher exact test. VF = ventricular fibrillation.

 

Figure 4
View larger version (23K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure 4 Distribution of J Waves Among Patients With Idiopathic VF, Matched Control Subjects, and Healthy Athletes

The bars show the percentage of individuals with J-point elevation in each of the 3 patient groups. The y axis denotes the percentage of patients with J-point elevation in any lead. The partition of each bar demonstrates the distribution of J-point elevation in the different leads (the numbers within the bars exceed 100%, because some patients had J-point elevation in more than 1 group of leads). VF = ventricular fibrillation.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement